Bioventus (NASDAQ:BVS) reported its Q4 earnings results on Thursday, March 10, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Bioventus beat estimated earnings by 44.44%, reporting an EPS of $0.26 versus an estimate of $0.18.
Revenue was up $31.82 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.11 which was followed by a 0.36% drop in the share price the next day.
Here's a look at Bioventus's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | 0.14 | 0.15 | 0.09 | 0.23 |
| EPS Actual | 0.25 | 0.16 | 0.15 | 2.32 |
| Revenue Estimate | 102.23M | 97.64M | 76.54M | 98.12M |
| Revenue Actual | 108.89M | 109.82M | 81.78M | 98.59M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
